PharmaCyte Biotech, Inc. logo

PharmaCyte Biotech, Inc. (PMCB) Q4 2024 Earnings

PMCB·Reported December 13, 2024·Before market open

Diluted EPS came in at $-0.29.

Diluted EPS
$-0.29
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q · 0001683168-24-008709

Financial Snapshot

Trailing eight quarters through Q4 2024

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q4 2024 Earnings FAQ

Common questions about PharmaCyte Biotech, Inc.'s Q4 2024 earnings report.

PharmaCyte Biotech, Inc. (PMCB) reported Q4 2024 earnings on December 13, 2024 before market open.

PharmaCyte Biotech, Inc. reported diluted EPS of $-0.29 for Q4 2024.

You can read the 10-Q periodic report (0001683168-24-008709) directly on SEC EDGAR. The filing index links above go to sec.gov.